Anzeige
Mehr »
Mittwoch, 22.10.2025 - Börsentäglich über 12.000 News
Das Comeback des Goldrauschs - diesmal ausgelöst durch eine Währungskrise
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JDMF | ISIN: US75062E1064 | Ticker-Symbol:
NASDAQ
21.10.25 | 22:00
1,375 US-Dollar
0,00 % 0,000
Branche
Immobilien
Aktienmarkt
Sonstige
1-Jahres-Chart
RAFAEL HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
RAFAEL HOLDINGS INC 5-Tage-Chart

Aktuelle News zur RAFAEL HOLDINGS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.10.Rafael Holdings, Inc. - 8-K, Current Report1
16.09.Rafael Holdings, Inc.: Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old6
27.08.Rafael Holdings, Inc.: Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)3
07.08.Rafael Holdings, Inc. - 8-K, Current Report3
18.07.Rafael Holdings beruft Scott Fine als Ex-officio-Direktor und ändert Satzung6
18.07.Rafael Holdings, Inc. - 8-K, Current Report3
26.06.Rafael Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans2
18.06.Rafael Holdings, Inc. - 8-K, Current Report6
RAFAEL HOLDINGS Aktie jetzt für 0€ handeln
18.06.Rafael Holdings, Inc.: Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week ...209Phase 3 TransportNPC study to continue based on the independent DMC review of safety and efficacy data at prespecified 48-week interim analysis Data on the investigational candidate Trappsol® Cyclo...
► Artikel lesen
11.06.Rafael Holdings, Inc. - 10-Q, Quarterly Report1
11.06.Rafael Holdings GAAP EPS of -$0.19, revenue of $0.36M1
10.06.Rafael Holdings stock surges after CEO acquires $16.7m in shares5
10.06.Rafael Holdings-Aktie steigt nach 16,7 Millionen US-Dollar Aktienkauf durch CEO16
04.06.Rafael Holdings, Inc. - 8-K, Current Report2
04.06.Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering294NEWARK, N.J., June 04, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) announced today the final results and closing of its $25.0 million rights offering (the "Rights...
► Artikel lesen
20.05.Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential ...14
06.05.Rafael Holdings, Inc. - 8-K, Current Report2
29.04.Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo3
26.03.Rafael Holdings, Inc.: Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals281NEWARK, N.J. and GAINESVILLE, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), and Cyclo Therapeutics, Inc. (NASDAQ: CYTH) today announced the closing of their business...
► Artikel lesen
13.03.Rafael Holdings, Inc.: Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results199The planned merger with Cyclo Therapeutics is anticipated to close in Q3 pending shareholder approvals Post-merger the Company intends to focus its efforts on Cyclo's lead clinical program Trappsol®...
► Artikel lesen
Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1